111 related articles for article (PubMed ID: 9017447)
1. Cell surface CD44v5 levels correlate with progesterone receptors and a tumor size > 2 cm in infiltrating ductal carcinomas of the breast.
Nuñez MI; Arias JI; Del Rio MC; Martinez MI; Alba A; Allende MT; Ruibal A
Int J Biol Markers; 1996; 11(4):220-2. PubMed ID: 9017447
[No Abstract] [Full Text] [Related]
2. [CD44v6 expression in er-negative and PgR-negative infiltrating ductal breast carcinomas].
Ruibal A; del Río MC; Arias JI
Med Clin (Barc); 2005 Oct; 125(12):475-6. PubMed ID: 16216206
[No Abstract] [Full Text] [Related]
3. [The cytosolic hyaluronic acid level defines several clinico-biological properties of CD44v5-positive infiltrating ductal carcinoma of the breast].
Ruibal A; Arias JI; Carmen del Río M; San Román JM; Lapeña G; Schneider J; Tejerina A
Med Clin (Barc); 2000 Jul; 115(6):201-7. PubMed ID: 11002457
[TBL] [Abstract][Full Text] [Related]
4. The significance of malignancies incidental to microcalcifications in breast spot localization biopsy specimens.
Rosenfeld I; Tartter PI; Gajdos C; Hermann G; Bleiweiss I
Am J Surg; 2001 Jul; 182(1):1-5. PubMed ID: 11532405
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic value of ADC and rADC of diffusion weighted imaging in malignant breast lesions].
Xie CM; Yin SH; Li H; Liu XW; Zhang Y; Lü YC; Zhang R; Li JP; Geng ZJ; Wu PH
Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):217-20. PubMed ID: 20450592
[TBL] [Abstract][Full Text] [Related]
6. [Hormone-dependent, diploid, infiltrating ductal breast carcinomas less than 2 cm in size: influence of an exclusive and moderate cellular proliferation on the clinicobiological features and recurrences of these malignant tumors].
Ruibal A; Arias JI
Rev Esp Med Nucl; 2002; 21(6):437-8. PubMed ID: 12425893
[No Abstract] [Full Text] [Related]
7. [Clinical-biological characteristics of infiltrating ductal carcinomas of the breast with estrogen receptor concentrations >300 fmol/mg protein].
Resino C; Arias JI; Del Río MC; Sánchez Hermosa C; Ruibal A
Rev Esp Med Nucl; 2001 Oct; 20(6):503-5. PubMed ID: 11578586
[No Abstract] [Full Text] [Related]
8. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
9. Study of the expression on the CD44v5 adhesion molecule in invasive lobular carcinomas of the breast. Association between negativity and cellular S-phase fraction >7%.
Ruibal A; Arias J; Del Rio MC; Schneider J; Tejerina A
Int J Biol Markers; 2000; 15(2):195-6. PubMed ID: 10883896
[No Abstract] [Full Text] [Related]
10. Nucleolar organizer regions in human breast cancer.
Roller E; Fritz P; Wicherek C; Klumpp B; Lauinger J; Mischlinski A; Wanner B; Schumacher K
Zentralbl Pathol; 1993 Aug; 139(3):195-9. PubMed ID: 8218120
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors of breast cancer].
Tang P; Wei B; Yang WJ; Liu YS; Bu H
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):73-6. PubMed ID: 21426799
[No Abstract] [Full Text] [Related]
12. New aspects in the histological diagnosis of breast carcinoma.
Shousha S
Semin Surg Oncol; 1996; 12(1):12-25. PubMed ID: 8821405
[TBL] [Abstract][Full Text] [Related]
13. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
Gould VE; Mosquera JM; Leykauf K; Gattuso P; Dürst M; Alonso A
Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
[TBL] [Abstract][Full Text] [Related]
14. [Expression of the adhesion molecule CD44v6 in infiltrating ductal carcinomas of the breast is associated with hormone dependence. Our experience with 168 cases].
Ruibal A; Schneider J; del Río MC; Arias J; Núñez MI; Tejerina A
Rev Esp Med Nucl; 2000 Sep; 19(5):350-5. PubMed ID: 11062111
[TBL] [Abstract][Full Text] [Related]
15. Automated image morphometry of lobular breast carcinoma.
Rajesh L; Dey P; Joshi K
Anal Quant Cytol Histol; 2002 Apr; 24(2):81-4. PubMed ID: 12026054
[TBL] [Abstract][Full Text] [Related]
16. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
[TBL] [Abstract][Full Text] [Related]
17. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
[TBL] [Abstract][Full Text] [Related]
18. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
19. Microglandular adenosis with transition to breast carcinoma: a series of three cases.
Lin L; Pathmanathan N
Pathology; 2011 Aug; 43(5):498-503. PubMed ID: 21753716
[No Abstract] [Full Text] [Related]
20. CD24 is a marker for human breast carcinoma.
Fogel M; Friederichs J; Zeller Y; Husar M; Smirnov A; Roitman L; Altevogt P; Sthoeger ZM
Cancer Lett; 1999 Aug; 143(1):87-94. PubMed ID: 10465342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
